---
title: "\"Performance\" Ascentage Pharma-B's losses widened to 1.243 billion RMB last year"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280545487.md"
description: "Ascentage-B announced its full-year results for the year ended last December, with a revenue of RMB 574 million, a year-on-year decrease of 41.5%. The loss widened to RMB 1.243 billion, compared to a loss of RMB 405 million in the same period last year; the loss per share was RMB 3.49. No final dividend will be distributed"
datetime: "2026-03-26T00:52:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280545487.md)
  - [en](https://longbridge.com/en/news/280545487.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280545487.md)
---

# "Performance" Ascentage Pharma-B's losses widened to 1.243 billion RMB last year

Ascentage-B (06855.HK) announced its full-year results for the year ended December last year, with revenue of RMB 574 million, a year-on-year decrease of 41.5%. Losses widened to RMB 1.243 billion, compared to a loss of RMB 405 million in the same period last year; loss per share was RMB 3.49. No final dividend will be declared

### Related Stocks

- [159570.CN](https://longbridge.com/en/quote/159570.CN.md)
- [06855.HK](https://longbridge.com/en/quote/06855.HK.md)
- [159837.CN](https://longbridge.com/en/quote/159837.CN.md)
- [159892.CN](https://longbridge.com/en/quote/159892.CN.md)
- [588130.CN](https://longbridge.com/en/quote/588130.CN.md)
- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [520880.CN](https://longbridge.com/en/quote/520880.CN.md)
- [159506.CN](https://longbridge.com/en/quote/159506.CN.md)
- [512010.CN](https://longbridge.com/en/quote/512010.CN.md)
- [159316.CN](https://longbridge.com/en/quote/159316.CN.md)
- [520690.CN](https://longbridge.com/en/quote/520690.CN.md)
- [510660.CN](https://longbridge.com/en/quote/510660.CN.md)
- [159992.CN](https://longbridge.com/en/quote/159992.CN.md)
- [516500.CN](https://longbridge.com/en/quote/516500.CN.md)
- [520500.CN](https://longbridge.com/en/quote/520500.CN.md)
- [516930.CN](https://longbridge.com/en/quote/516930.CN.md)
- [513120.CN](https://longbridge.com/en/quote/513120.CN.md)
- [159849.CN](https://longbridge.com/en/quote/159849.CN.md)
- [513700.CN](https://longbridge.com/en/quote/513700.CN.md)

## Related News & Research

- [Grand Pharmaceutical Moves to Adopt New Bye-Laws Aligned With HK Paperless Regime](https://longbridge.com/en/news/284576690.md)
- [Onco-Innovations Announces Inka Health Collaborative Research to Advance Oncology Evidence Generation | ONNVF Stock News](https://longbridge.com/en/news/285274936.md)
- [07:55 ETSupport Egg Quality and Ovulation with Nature's Bounty® New Fertility Supplement*](https://longbridge.com/en/news/285200796.md)
- [ZAWYA: Emirates Drug Establishment approves first nasal epinephrine spray as alternative to injections for severe allergic reaction](https://longbridge.com/en/news/284603051.md)
- [Samsung Bioepis Announces Positive Preliminary Phase 1 Data for SB27, Proposed Biosimilar to Keytruda (Pembrolizumab)](https://longbridge.com/en/news/285280098.md)